The 9.5mm diameter version of the implant was cleared by the FDA in January and was awarded the FDA’s breakthrough device designation and a New Technology Add-on Payment by CMS, according to a news release.
The smaller implant for sacroiliac joint fusion and spinopelvic fixation is designed for patients with smaller anatomy and may allow for easier placement of stacked implants. The FDA’s clearance for the device includes use in the S1 body of the sacrum and pediatric deformity.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
